Science & Enterprise subscription

Follow us on Twitter

  • As the race to produce and distribute Covid-19 vaccines intensifies, financing of this global public health project… https://t.co/pyDX0IWnCs
    about 5 hours ago
  • New post on Science and Enterprise: Infographic – Public Money Funds Covid-19 Vaccines https://t.co/1D2XLhUi4Z #Science #Business
    about 5 hours ago
  • Excellent analysis. Real example: a colleague I hired at Science mag is leaving her job to get a grad degree in IT. https://t.co/c0qnYW025H
    about 8 hours ago
  • Two biotechnology companies are collaborating on using the gene editing technique Crispr to create engineered immun… https://t.co/4lK4qD5p6m
    about 1 day ago
  • New post on Science and Enterprise: Biotechs Partner on Gene-Edited Cancer Cell Therapies https://t.co/ck7tBkXfXF #Science #Business
    about 1 day ago

Please share Science & Enterprise

Antibody Clears Covid-19 Variants, Enters Trial

SARS-Cov-2 virus

A synthetic antibody is shown in lab tests to neutralize variants of the SARS-CoV-2 virus, and will be added to an ongoing clinical trial of Covid-19 therapies. . . . → Read More: Antibody Clears Covid-19 Variants, Enters Trial

Vaccine Stops Lyme Bacteria in Preclinical Test

Adult deer tick

A study with lab mice shows an experimental vaccine with engineered bacteria produces antibodies and protects against microbes causing Lyme disease. . . . → Read More: Vaccine Stops Lyme Bacteria in Preclinical Test

Small Biz Grant Funds Wrist Fracture Adhesive

Broken wrist in cast

A company developing a biocompatible material to aid bone healing will test the substance on treating simulated wrist fractures in large animals. . . . → Read More: Small Biz Grant Funds Wrist Fracture Adhesive

Infectious Disease Biotech Raises $100M in Venture Funds

Syringe and three vials

A biotechnology company designing vaccines for viral diseases including Covid-19 is raising $100 million in its second venture funding round. . . . → Read More: Infectious Disease Biotech Raises $100M in Venture Funds

Graphene Crispr Chip Detects Small Genetic Differences

DNA chip graphic

An academic-industry team designed a computer chip with graphene circuits using the gene-editing technique Crispr to detect fine genetic differences in samples. . . . → Read More: Graphene Crispr Chip Detects Small Genetic Differences

Test Vaccine Protects Against Wide Coronavirus Range

Two piglets

Researchers at two Virginia universities developed an experimental vaccine that in tests with pigs protects against SARS-CoV-2 and other coronaviruses. . . . → Read More: Test Vaccine Protects Against Wide Coronavirus Range

Fast, Inexpensive Covid-19 Immunity Test Devised

Drop of blood

Researchers in Canada developed a simple and inexpensive test for Covid-19 antibodies requiring a pinprick of blood, and returning results in under an hour. . . . → Read More: Fast, Inexpensive Covid-19 Immunity Test Devised

Synthetic Antibodies Shown to Control Blood Glucose

DNAmolcule model

A company creating biologics derived from synthetic DNA and genes discovered antibodies that control blood glucose levels in lab animals. . . . → Read More: Synthetic Antibodies Shown to Control Blood Glucose

Joint Venture Developing Oral Covid-19 Vaccine

Capsules in a glass

Two biotechnology companies are forming a new enterprise to produce a vaccine as a capsule or tablet to protect against Covid-19 infections. . . . → Read More: Joint Venture Developing Oral Covid-19 Vaccine

Engineered Macrophage Cells Tested in Cancer Trial

Macrophage

A clinical trial is underway testing immune system cells called macrophages, with added cancer-killing proteins, as a treatment for solid tumor cancers. . . . → Read More: Engineered Macrophage Cells Tested in Cancer Trial